Records containing: Renal Cell Carcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-07-22
Optimizing Intervention Tools to Improve Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
CLINICAL_TRIALS study record update · 2025-07-18
A Phase Ib/II Open Label, Multi-arm, Parallel Cohort Dose Finding and Expansion Study to Assess the Safety, Pharmacokinetics and Efficacy of NUC-3373, a Nucleotide Analogue, Given in Combination With Standard Approved Agents in Patients With Advanced Solid Tumours
CLINICAL_TRIALS study record update · 2025-07-11
A National, Prospective, Non-Interventional Study (NIS) in Patients With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy
CLINICAL_TRIALS study record update · 2025-07-02
Phace I and II Study of Immunotherapy Strategy Used iNKT Cells and CD8+T Cells in Patients With Advanced Tumor
CLINICAL_TRIALS study record update · 2025-06-27
Znaczenie Kliniczne przywierającego tłuszczu okołonerkowego u pacjentów Poddawanych Resekcji Guza Nerki
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-06-26
E-Interventions to Treat Fear of Cancer Recurrence for Patients With Localized Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2025-06-25
A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (BMS-936558) With or Without Ipilimumab (BMS-734016) in Patients With Advanced Renal Cell Carcinoma in Real Life Setting
CLINICAL_TRIALS study record update · 2025-06-15
A Phase 1 Dose-escalation and Expansion Study of the PD-1 x ILT4 Bispecific Antibody CDX-585 in Patients With Advanced Malignancies
CLINICAL_TRIALS study record update · 2025-06-12
Pilot Study to Describe the Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2025-06-06
A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)
CLINICAL_TRIALS study record update · 2025-06-06
Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Single-arm Phase lI Trial
CLINICAL_TRIALS study record update · 2025-06-06
PROspective Renal Cancer Cohort (PRO-RCC)
CLINICAL_TRIALS study record update · 2025-06-05
Randomized Phase III Trial of Standard Immunotherapy (IO) by Checkpoint Inhibitors, Versus Reduced Dose Intensity of IO in Patients With Locally Advanced or Metastatic Cancer in Response After 6 Months of Standard IO
CLINICAL_TRIALS study record update · 2025-05-31
A Phase I Clinical Study of CD70-targeting CAR-T Therapy in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
CLINICAL_TRIALS study record update · 2025-05-29
Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management - a Randomised Feasibility Study
CLINICAL_TRIALS study record update · 2025-05-28
A PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ESCALATING DOSES OF PF-06940434 IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS
CLINICAL_TRIALS study record update · 2025-05-28
A Phase Ib/II Study of Talazoparib and Axitinib in Metastatic Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2025-05-20
Treatment Plan of the HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
CLINICAL_TRIALS study record update · 2025-05-15
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
CLINICAL_TRIALS study record update · 2025-05-13
PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
CLINICAL_TRIALS study record update · 2025-05-02
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
CLINICAL_TRIALS study record update · 2025-05-02
Contrast-Enhanced Ultrasound for the Evaluation of Renal Cell Carcinoma Cryoablation
CLINICAL_TRIALS study record update · 2025-04-25
Cyto-KIK; TRIAL (CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy (Nivolumab) and Targeted Kinase Inhibition (Cabozantinib)
CLINICAL_TRIALS study record update · 2025-04-24
Proof of Concept for Lenvatinib and Everolimus Prior to Nephrectomy in Eligible Patients With Local and Metastatic Renal Cell Carcinoma (RCC)
CLINICAL_TRIALS study record update · 2025-04-23
A Phase 1/2a, Multicenter, Open-label Trial of TBio-6517, an Oncolytic Vaccinia Virus, Administered Alone and in Combination With Pembrolizumab, in Patients With Advanced Solid Tumors